These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29140263)

  • 1. Access to Guideline-Recommended Pharmacogenomic Tests for Cancer Treatments: Experience of Providers and Patients.
    Wu AC; Mazor KM; Ceccarelli R; Loomer S; Lu CY
    J Pers Med; 2017 Nov; 7(4):. PubMed ID: 29140263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Implementation Process for Pharmacogenomic Testing for Cancer-Targeted Therapies.
    Wu AC; Mazor KM; Ceccarelli R; Loomer S; Lu CY
    J Pers Med; 2018 Oct; 8(4):. PubMed ID: 30275409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of patient perceptions of genomic testing to inform pharmacogenomic implementation.
    Lee YM; McKillip RP; Borden BA; Klammer CE; Ratain MJ; O'Donnell PH
    Pharmacogenet Genomics; 2017 May; 27(5):179-189. PubMed ID: 28267054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary care provider perceptions of enablers and barriers to following guideline-recommended laboratory tests to confirm chronic kidney disease: a qualitative descriptive study.
    Nash DM; Garg AX; Brimble KS; Markle-Reid M
    BMC Fam Pract; 2018 Dec; 19(1):192. PubMed ID: 30526501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insurance Coverage Policies for Pharmacogenomic and Multi-Gene Testing for Cancer.
    Lu CY; Loomer S; Ceccarelli R; Mazor KM; Sabin J; Clayton EW; Ginsburg GS; Wu AC
    J Pers Med; 2018 May; 8(2):. PubMed ID: 29772692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient and Health Care Provider Needs and Preferences in Understanding Pharmacogenomic and Genomic Testing: A Meta-Data Analysis.
    Veilleux S; Bouffard M; Bourque Bouliane M
    Qual Health Res; 2020 Jan; 30(1):43-59. PubMed ID: 31322055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary care physician experiences with integrated pharmacogenomic testing in a community health system.
    Lemke AA; Hutten Selkirk CG; Glaser NS; Sereika AW; Wake DT; Hulick PJ; Dunnenberger HM
    Per Med; 2017 Sep; 14(5):389-400. PubMed ID: 29754567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applicability of Pharmacogenomically Guided Medication Treatment during Hospitalization of At-Risk Minority Patients.
    Saulsberry L; Danahey K; Middlestadt M; O'Leary KJ; Nutescu EA; Chen T; Lee JC; Ruhnke GW; George D; House L; van Wijk XMR; Yeo KJ; Choksi A; Hartman SW; Knoebel RW; Friedman PN; Rasmussen LV; Ratain MJ; Perera MA; Meltzer DO; O'Donnell PH
    J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomic technologies: a necessary "luxury" for better global public health?
    Olivier C; Williams-Jones B
    Global Health; 2011 Aug; 7():30. PubMed ID: 21864366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing Pharmacogenomic-Guided Medication Use With a Clinical Data Repository.
    Mathias PC; Hendrix N; Wang WJ; Keyloun K; Khelifi M; Tarczy-Hornoch P; Devine B
    Clin Pharmacol Ther; 2017 Aug; 102(2):340-348. PubMed ID: 28073152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study.
    Borden BA; Galecki P; Wellmann R; Danahey K; Lee SM; Patrick-Miller L; Sorrentino MJ; Nanda R; Koyner JL; Polonsky TS; Stadler WM; Mulcahy C; Kavitt RT; Ratain MJ; Meltzer DO; O'Donnell PH
    Pharmacogenet Genomics; 2019 Feb; 29(2):31-38. PubMed ID: 30531377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilizing a user-centered approach to develop and assess pharmacogenomic clinical decision support for thiopurine methyltransferase.
    Nguyen KA; Patel H; Haggstrom DA; Zillich AJ; Imperiale TF; Russ AL
    BMC Med Inform Decis Mak; 2019 Oct; 19(1):194. PubMed ID: 31623616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stakeholder views on pharmacogenomic testing.
    Patel HN; Ursan ID; Zueger PM; Cavallari LH; Pickard AS
    Pharmacotherapy; 2014 Feb; 34(2):151-65. PubMed ID: 24167008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Provider responses to patients controlling access to their electronic health records: a prospective cohort study in primary care.
    Tierney WM; Alpert SA; Byrket A; Caine K; Leventhal JC; Meslin EM; Schwartz PH
    J Gen Intern Med; 2015 Jan; 30 Suppl 1(Suppl 1):S31-7. PubMed ID: 25480720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What matters to people with chronic conditions when accessing care in Australian general practice? A qualitative study of patient, carer, and provider perspectives.
    Song HJ; Dennis S; Levesque JF; Harris MF
    BMC Fam Pract; 2019 Jun; 20(1):79. PubMed ID: 31182041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of respiratory tract infections in young children-A qualitative study of primary care providers' perspectives.
    Biezen R; Brijnath B; Grando D; Mazza D
    NPJ Prim Care Respir Med; 2017 Mar; 27(1):15. PubMed ID: 28258279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient organization involvement and the challenge of securing access to treatments for rare diseases: report of a policy engagement workshop.
    Mikami K; Sturdy S
    Res Involv Engagem; 2017; 3():14. PubMed ID: 29062539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-medical facilitators and barriers towards accessing haemodialysis services: an exploration of ethical challenges.
    Pancras G; Shayo J; Anaeli A
    BMC Nephrol; 2018 Dec; 19(1):342. PubMed ID: 30509208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer patients acceptance, understanding, and willingness-to-pay for pharmacogenomic testing.
    Cuffe S; Hon H; Qiu X; Tobros K; Wong CK; De Souza B; McFarlane G; Masroor S; Azad AK; Hasani E; Rozanec N; Leighl N; Alibhai S; Xu W; Issa AM; Liu G
    Pharmacogenet Genomics; 2014 Jul; 24(7):348-55. PubMed ID: 24911662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge and understanding of pharmacogenomic testing among patients and health care professionals: A scoping review.
    Veilleux S; Bouffard M
    Patient Educ Couns; 2019 Nov; 102(11):2001-2009. PubMed ID: 31229328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.